Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Consumers Search for Healthy Cleaning Products That Work
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- Heartburn Relief in 20 Days? -- New Natural Product From Enzymatic Therapy Provides Promising, Lasting Results on Occasional Heartburn in Clinical Trial
- Heartburn Relief in 20 Days? -- New Natural Product From Enzymatic Therapy Provides Promising, Lasting Results on Occasional Heartburn in Clinical Trial
- Top GNC Executives Tour Chicago Market to Present New Business Plan and Expansion Possibilities; Meeting Will Focus On New Business Strategies and Growth
- Leiner Health Products Appoints Robert Reynolds as Chief Financial Officer
- Cyanotech Japan YK Formed to Service Growing Market Demand
- Cyanotech Japan YK Formed to Service Growing Market Demand
- Cyanotech Japan YK Formed to Service Growing Market Demand
- Leading Pharmaceutical Company Chooses Emagia to Optimize Cash Inflow
- Second Infant Formula Company Announces Plans for U.S. Launch of Formula with Martek's Oils
- Second Infant Formula Company Announces Plans for U.S. Launch of Formula with Martek's Oils
- Second Infant Formula Company Announces Plans for U.S. Launch of Formula with Martek's Oils
- Have You Eaten Enough Bacteria Today?
- Have You Eaten Enough Bacteria Today?
- American Health & Diet Centers, dba The Nutritionary, Launches New Website
- Natural Health Trends Corp. Enters Caribbean Market;
- Natural Health Trends Corp. Enters Caribbean Market;
- The Vitamin Shoppe Opens 100th Store Nationwide in New Jersey; The Vitamin Shoppe Donates To Local Police and Emergency Services Departments
- New Hope for Children with Learning Disorders - All-Natural Dietary Supplements Show Promise to Improve Symptoms of Dyslexia and Attention-Deficit/Hyperactivity Disorder
- New Hope for Children with Learning Disorders - All-Natural Dietary Supplements Show Promise to Improve Symptoms of Dyslexia and Attention-Deficit/Hyperactivity Disorder
- Court Affirms that Companies Must Report Hazardous Products Immediately to CPSC
- Court Affirms that Companies Must Report Hazardous Products Immediately to CPSC
- Congress Funds Research Program to Determine Impact of Daily Vitamins on School Performance of At-Risk Children
- Congress Funds Research Program to Determine Impact of Daily Vitamins on School Performance of At-Risk Children
- Nutrition 21 Names Eric W. Klar as Business Director of Its Consumer Products Operations
- Nutrition 21 Names Eric W. Klar as Business Director of Its Consumer Products Operations
- Nordic Naturals Receives Special Patent for Flavored Gel Caps
- Nordic Naturals Receives Special Patent for Flavored Gel Caps
- Phytomedics Inc. and Degussa AG Enter Strategic Collaboration
- Phytomedics Inc. and Degussa AG Enter Strategic Collaboration
- Chemi Nutra Launches Web Site: www.cheminutra.com
- FASMAC Co. Ltd., of Kanagawa, Japan, names GeneScan USA, Inc. as its exclusive licensee in North America
- FASMAC Co. Ltd., of Kanagawa, Japan, names GeneScan USA, Inc. as its exclusive licensee in North America
- Chairman of the House of Representatives Demands Answers from FDA.
- Chairman of the House of Representatives Demands Answers from FDA.
- FDA Responds to House of Representatives request
- FDA Responds to House of Representatives request
- BioCell Technology, LLC Launches Web Site In Support Of BioCell Collagen II: www.biocelltechnology.com
- American Herbal Pharmacopoeia Publishes Black cohosh (Actaea racemosa syn. Cimicifuga racemosa ) Monograph
- Indena's SabaSelect Chosen By NIH for Sponsored Clinical Trial
- Indena's SabaSelect Chosen By NIH for Sponsored Clinical Trial
- Phytomedics Inc. and Henkel KGaA Enter Collaboration
- USANA Health Sciences Calls for IOC to Certify Supplements; Proposal for Industry/IOC Cooperative Effort
- USANA Health Sciences Calls for IOC to Certify Supplements; Proposal for Industry/IOC Cooperative Effort
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- UK's Luscious Organic and Low Fat Launches Bid for Third Round Funding To Go Global.
- Athletic Banned Substances Screening and Certification Program Announced by ConsumerLab.com
- Athletic Banned Substances Screening and Certification Program Announced by ConsumerLab.com
- Nutraceutix Annouces Issuance of CDT™ Patent
- Nutraceutix Annouces Issuance of CDT™ Patent
- Nutraceutix Annouces Issuance of CDT™ Patent
- Nutraceutix Annouces Issuance of CDT™ Patent
- The Most Comprehinsive Traditional Chinese Medicine Professional Database Now Available From Intramedicine, Inc.
- Dietary Supplement Education Alliance™ Backed by Corporate Alliance for Integrative Medicine
- Dietary Supplement Education Allicance Merges with Corporate Alliance for Integrative Medicine
- Naturally Vitamins Extends Contract for Exclusive Distribution Rights Of Wobenzym® in the United States
- Naturally Vitamins Extends Contract for Exclusive Distribution Rights Of Wobenzym® in the United States
- After 22 Years of Continuous Growth, Publicly Traded Arkopharma is know as the EU Leader in Natural Medicines
- Fewer Than One in Ten Women Realize That Heart Disease is Thier Number One Cause of Death
- Fewer Than One in Ten Women Realize That Heart Disease is Thier Number One Cause of Death
- Fewer Than One in Ten Women Realize That Heart Disease is Thier Number One Cause of Death
- Phytomedics Inc. and Eisai Research Institute of Boston, Inc. Enter Cancer Therapeutic Discovery Collaboration
- Nutra Products, Inc. Begins Operations, Supplies Nutraceutical Garlic and Other Ingredients
- Madaus, Inc. Appoints James H. Bruce as President and CEO
- Green Marketing offers MBA-level Management Expertise
- Clinical Phase II Study on Promising Japanese Botanical Formula 'Sho-Saiko-to' For Treating Liver Cancer to Begin in New York
- New Study Finds That Stabalized Rice Bran May Help 35 Million Diabetics By Lowering Blood Glucose Levels
- New Study Finds One in Five Seniors Using Alternative Medicine
- Lester M. Crawford Jr. Named FDA Deputy Commissioner
- Lester M. Crawford Jr. Named FDA Deputy Commissioner
- Nutraceutical Clinical Laboratories International, Inc. Announces Two New Appointments
- Roche Says Vitamin, Fine Chemicals Division Could be Spun Off
- General Nutrition Centers, Inc. Reports FY09 Q3 Results
General Nutrition Centers, Inc., has announced their FY09 Q3 results, reporting consolidated revenues of $430.8 million, an increase of 4.0% over the consolidated revenues of $414.2 million for the same quarter of 2008.
- General Nutrition Centers, Inc. Reports FY09 Q3 Results
General Nutrition Centers, Inc., has announced their FY09 Q3 results, reporting consolidated revenues of $430.8 million, an increase of 4.0% over the consolidated revenues of $414.2 million for the same quarter of 2008.
- General Nutrition Centers, Inc. Reports FY09 Q3 Results
General Nutrition Centers, Inc., has announced their FY09 Q3 results, reporting consolidated revenues of $430.8 million, an increase of 4.0% over the consolidated revenues of $414.2 million for the same quarter of 2008.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health
Bayer Consumer Care has announced the launch of their new Citracal(R) Calcium plus Heart Health for bone and heart care.
- Senomyx Announces Corporate Update and FY09 Q3 Results
Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%.
- Senomyx Announces Corporate Update and FY09 Q3 Results
Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%.
- Senomyx Announces Corporate Update and FY09 Q3 Results
Senomyx, Inc., has announced their FY09 Q3 results, reporting revenues were $4.2 million for the third quarter of 2009, compared to $4.0 million for the third quarter of 2008, an increase of 3%.
- GLG Life Tech Corporation Announces Receipt of Demand Letter
GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company.
- GLG Life Tech Corporation Announces Receipt of Demand Letter
GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company.
- GLG Life Tech Corporation Announces Receipt of Demand Letter
GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company.
- GLG Life Tech Corporation Announces Receipt of Demand Letter
GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company.
- GLG Life Tech Corporation Announces Receipt of Demand Letter
GLG Life Tech Corporation has announced that it has received a demand letter from Weider Global Nutrition that states that WGN will commence, on November 4, 2009, legal proceedings in the Supreme Court of British Columbia against the Company.
- Ingredients Manufacturer Goes Small
Taura Natural Ingredients has announced their new Mini Fruit Bits.
- Ingredients Manufacturer Goes Small
Taura Natural Ingredients has announced their new Mini Fruit Bits.
- Ingredients Manufacturer Goes Small
Taura Natural Ingredients has announced their new Mini Fruit Bits.
- Ingredients Manufacturer Goes Small
Taura Natural Ingredients has announced their new Mini Fruit Bits.
- Ingredients Manufacturer Goes Small
Taura Natural Ingredients has announced their new Mini Fruit Bits.
- Ingredients Manufacturer Goes Small
Taura Natural Ingredients has announced their new Mini Fruit Bits.
- Ingredients Manufacturer Goes Small
Taura Natural Ingredients has announced their new Mini Fruit Bits.
- MGP Ingredients, Inc. Announces FY10 Q1 Results
MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009.
- MGP Ingredients, Inc. Announces FY10 Q1 Results
MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009.
- MGP Ingredients, Inc. Announces FY10 Q1 Results
MGP Ingredients, Inc., has announced their FY10 Q1 results, reporting net income of $3,738,000, or $0.22 in diluted earnings per share, for the first quarter of fiscal 2010, which ended September 30, 2009. This compares with a net loss of $17,243,000, or $1.04 in diluted loss per share, for the first quarter of fiscal 2009. The increase in earnings was primarily the result of an improved sales mix of value-added products, reductions in grain and energy costs, and lower payroll costs as a result of restructuring completed in fiscal year 2009.
- Whole Foods Market Reports FY09 Q4 Results
Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%.
- Whole Foods Market Reports FY09 Q4 Results
Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%.
- Whole Foods Market Reports FY09 Q4 Results
Whole Foods Market, Inc., has announced their FY09 Q4 results, reporting sale for the quarter increased 2.3% to $1.8 billion. Comparable store sales decreased 0.9% versus a 0.4% increase in the prior year. Identical store sales, excluding eight relocations and two major expansions, decreased 2.3% versus a 0.5% decrease in the prior year. Excluding the negative impact of foreign currency translation, comparable store sales decreased 0.7%, and identical store sales decreased 2.0%.
- New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid
KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults.
- New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid
KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults.
- New Study Shows Vitamin C with Metabolites Reduces Oxalate Levels Compared to Ascorbic Acid
KGK Synergize Inc., has announced study results published in Urologic Nursing, which identify a significant change in 24-hour urine oxalate levels among two treatments. The study was conducted as a randomized, double-blind, crossover trial of vitamin C with metabolites (Ester-C®) compared to ascorbic acid in 50 healthy adults.
|
Westlake Village, Calif. -Intramedicine, Inc. (IM), a leading health information publishing and new technology services company, will provide licenses to their online professional integrative medical database and their patent pending CD Information Sales Technology (CDIST) to the Better Life Institute (BLI), which will offer the products through its Web site and Partner Store affiliation with www.quixtar.com.
The Better Life Institute, a health-education company located in Grand Rapids, Mich., will add Intramedicine's integrative medical content and technology to its existing comprehensive product offering geared towards healthcare professionals and consumers interested in leading healthier and better lives. BLI's health education services primarily support hundreds of thousands of Independent Business Owners powered by Quixtar Inc., an e-commerce venture.
"After reviewing all information sources in the integrative and complementary medicine field, we found Intramedicine to be superior in providing quality science-based information on supplements and their complementary use with specific health conditions" expressed Ted Walters, VP/Associate Director of BLI. "We also found IM's CDIST product to be the only information and technology system that provides us with the critical link between quality information and increased product sales."
"We are excited to be working with BLI, and the expansive reach that the network of independent business owners they support can provide," stated Jeffrey Eisenberg, CEO of Intramedicine. "Our relationship with BLI is yet another example of our unique business methodology, which is, in addition to providing our clients with quality information, giving them the technology, sales and marketing tools to grow their business."
The Better Life Institute introduced the Intramedicine program to Quixtar IBOs at Achievers, an annual incentive trip hosted by Quixtar each October.
About Intramedicine, Inc.
Intramedicine, Inc. is a leading health information publishing and new technology company, which has developed proprietary technology to manage and dynamically deliver vast content libraries to its end-users. The Company has executed the first phase of its business plan by developing the preeminent science-based information database in the field of integrative medicine, which, as a digital publisher, can be delivered online, via CD Rom, books, newsletters, continuing education or seminars. Intramedicine is currently the global source for integrative medical information for the healthcare, pharmaceutical, pharmacy, and natural product manufacturing industries. Intramedicine researches the full range of scientifically validated complementary and conventional medical therapies available throughout the world and provides clinical data in support of how these medical disciplines work best in synergy. Intramedicine is a content and technology Partner with the DSEA/DSIB. General information about Intramedicine is available at our web site at .
About Better Life Institute
The Better Life Institute is a health-education company that examines the latest research and utilizes the best of technological advancements to make high-level scientific data on health and nutrition available in a variety of user-friendly formats, created to be easily understood by people of all ages, cultures and nationalities. Through seminars, books, white papers, audiotapes and videotapes, health assessments, and website, BLI provides information designed to be up-to date and incorporated into today's hectic lifestyles, so everyone can create a better life. The Better Life Institute was founded in Grand Rapids, Michigan in 1986 by Steven M. Zifferblatt and his wife Patricia Walters Zifferblatt. General information about the Better Life Institute is available at our web site at www.blionline.com
Elaine Roche
Marketing Director
Intramedicine, Inc.
790 Hampshire Rd. Suite H
Westlake Village, CA 91361
Ph (805) 373-8715
Fax (805) 371-9510
www.intramedicine.com
|